Scientific article

Co-infection tuberculose et VIH: enjeux thérapeutiques

Published inRevue médicale suisse, vol. 7, no. 318, p. 2295-2296,2298-300
Publication date2011

Tuberculosis (TB) is the most frequent opportunistic infection in patients infected by the Human immunodeficiency virus (HIV). The mortality related to this co-infection can be reduced by the early introduction of an antiretroviral treatment. However, when treating subjects with TB and HIV, interactions between antiretroviral and tuberculostatic treatments can be problematic; also, these patients may develop, under treatment, an immune reconstitution inflammatory syndrome (IRIS). This review aims to summarize the necessary therapeutic adjustments which should be performed when treating patients co-infected with TB and HIV, the most important interactions between HIV and TB treatments, and the medical management of the IRIS.

  • AIDS-Related Opportunistic Infections/drug therapy
  • Antiretroviral Therapy, Highly Active/adverse effects
  • Antitubercular Agents/adverse effects/therapeutic use
  • Choice Behavior
  • Coinfection/drug therapy
  • HIV Infections/complications/drug therapy
  • Humans
  • Immune Reconstitution Inflammatory Syndrome/chemically induced
  • Models, Biological
  • Tuberculosis/complications/drug therapy
Research group
Citation (ISO format)
CHARBONNIER, Florian, CALMY, Alexandra, JANSSENS, Jean-Paul. Co-infection tuberculose et VIH: enjeux thérapeutiques. In: Revue médicale suisse, 2011, vol. 7, n° 318, p. 2295–2296,2298–300.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation12/03/2013 2:28:00 PM
First validation12/03/2013 2:28:00 PM
Update time03/14/2023 8:40:00 PM
Status update03/14/2023 8:40:00 PM
Last indexation08/29/2023 7:24:56 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack